Blood

Diffuse large B-cell lymphoma of the central nervous system

4

studies recruiting now

as of 7 Sept 2026

50

studies registered in total

as of 7 Sept 2026

3

countries with a recruiting site

as of 7 Sept 2026

6 Aug 2026

most recent study posted

among recruiting studies

Recruiting trials

RecruitingPhase 2NCT04792489

DALY II USA/ MB-CART2019.1 for DLBCL

Sponsor Miltenyi Biomedicine GmbHWhere United States, Canada (32 sites)Studying zamtocabtagene autoleucel (MB-CART2019.1), CyclophosphamideUpdated 13 Jul 2026

Showing the 4 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

Search all Diffuse large B-cell lymphoma of the central nervous system studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Keep watching

Get an email when a new Diffuse large B-cell lymphoma of the central nervous system study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Diffuse large B-cell lymphoma of the central nervous system

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).